Magnet Biomedicine has entered a partnership and licence agreement with Eli Lilly to discover, develop and commercialise ...
It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. The company has ...
As STAT’s Helen Branswell writes, mRNA vaccines are the fastest to make and the easiest to mass produce.